About Human BioSciences
Human BioSciences is a company based in Gaithersburg (United States) founded in 1990 by Manoj Jain. It operates as a B2B and D2C. Human BioSciences offers products and services including Medifil® II, SkinTemp® II, and Collatek® Gel. Human BioSciences operates in a competitive market with competitors including QBiotics, MediWound, Ilya Pharma, Resolution Therapeutics and ProFibrix, among others.
- Headquarter Gaithersburg, United States
- Founders Manoj Jain
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Human Biosciences India Limited
- Date of Incorporation 11 Sep, 2000
- Jurisdiction New Delhi, Delhi, India
-
Annual Revenue
$140.16 K (USD)94.43as on Mar 31, 2022
-
Net Profit
$1.85 M (USD)613.01as on Mar 31, 2022
-
EBITDA
-$22.21 K (USD)-104.45as on Mar 31, 2022
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Human BioSciences
Human BioSciences offers a comprehensive portfolio of products and services, including Medifil® II, SkinTemp® II, and Collatek® Gel.
Collagen dressing for effective wound healing and management.
Skin substitute aiding in wound recovery and tissue repair.
Gel formulation for treating various types of wounds.
People of Human BioSciences
Unlock access to complete
Funding Insights of Human BioSciences
Detailed funding history for Human BioSciences
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Human BioSciences
Investment portfolio details for Human BioSciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Human BioSciences
Detailed financials for Human BioSciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Human Biosciences Comparisons
Peer comparison for Human BioSciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Human BioSciences
Human BioSciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as QBiotics, MediWound, Ilya Pharma, Resolution Therapeutics and ProFibrix, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Small molecules from plant extracts are developed for medical applications.
|
|
| Locked | Locked | Locked |
Enzymatic therapies for tissue repair and regeneration are developed.
|
|
| Locked | Locked | Locked |
Biological drugs for skin and mucosa wound treatment are developed.
|
|
| Locked | Locked | Locked |
Macrophage cell therapies are developed for inflammatory and liver diseases.
|
|
| Locked | Locked | Locked |
Powdered fibrin sealant for surgical bleeding
|
|
| Locked | Locked | Locked |
Topical formulations for corneal wounds, ulcers, and scars are developed.
|
Detailed competitors of Human BioSciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Human Biosciences
Complete news archive for Human BioSciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Human BioSciences
Human BioSciences was founded in 1990.
Human BioSciences is headquartered in Gaithersburg, United States. It is registered at Gaithersburg, Maryland, United States.
Manoj Jain is the current CEO of Human BioSciences. They have also founded this company.
Annual revenue of Human BioSciences is $140.16K as on Mar 31, 2022.
Human BioSciences focuses on creating and supplying collagen-based products for wound healing and care. They offer prescription and over-the-counter items like Medifil II and SkinTemp II, along with research and manufacturing services. Based in Gaithersburg, MD, USA, and Ahmedabad, India, they serve patients, professionals, and partners through collaborations and online platforms, emphasizing innovation in healthcare.
Human BioSciences's top competitors include Ilya Pharma, QBiotics and Tempo Therapeutics.
Human BioSciences offers Medifil® II, SkinTemp® II, and Collatek® Gel.